Physician profile
Kyle Kye
NPI 1447732680
$1,131.86
in general payments reported to CMS, 2019-2025
11 companies · $367 in 2025
The $367 reported for 2025 was more than what a typical Surgical provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $58.72 · 2022: $29.68 · 2023: $385 · 2024: $292 · 2025: $367.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,043.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,043.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $607.74 | 2023-2025 | Excelsiusgps Robotic Navigation System, Excelsius Gps, Direct Look |
| Csl Behring | $149.14 | 2023-2025 | Kcentra |
| Stryker Corporation | $85.28 | 2024-2025 | Adherus Autospray Dural Sealant, Vsp System, Vsp Cranial |
| Integra Lifesciences Corporation | $64.46 | 2025 | Duraseal Exact Spinal Sealant System, Cusa Clarity, Codman Hakim |
| Si-Bone, INC. | $58.72 | 2021 | |
| Alexion Pharmaceuticals, INC. | $32.15 | 2025 | Ultomiris |
| Aucta Pharmaceuticals, INC. | $30.97 | 2025 | Motpoly Xr |
| Gt Medical Technologies, INC | $29.68 | 2022 | |
| Neurelis, INC. | $28.51 | 2024 | Valtoco |
| Depuy Synthes Sales INC. | $23.79 | 2025 | Teligen |
| Novo Nordisk INC | $21.42 | 2024 | Ozempic, Rybelsus |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kyle Kye listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.